Home NDC 0187-0938 Tasmar
Product NDC 0187-0938
11-digit product format 001870938
Labeler code 0187
Product ID 0187-0938_b5c3a96c-28c4-40b3-8b44-e977c4ca2a9c
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Tolcapone
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Bausch Health US LLC
Application NDA020697
Marketing category NDA
Marketing start 2004-07-27
Substance TOLCAPONE
Active strength 100 mg/1
Pharmacologic classes Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 12 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N020697-001 TASMAR TOLCAPONE 100MG TABLET / ORAL RLD, RS 1998-01-29 N020697-002 TASMAR TOLCAPONE 200MG TABLET / ORAL 1998-01-29
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 84 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N020697-001 TASMAR 100MG TABLET / ORAL RLD, RS 1998-01-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N020697-002 TASMAR 200MG TABLET / ORAL 1998-01-29 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N020697-001 TASMAR 100MG TABLET / ORAL AB RLD, RS 1998-01-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020697-002 TASMAR 200MG TABLET / ORAL 1998-01-29 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020697-001 TASMAR 100MG TABLET / ORAL AB RLD, RS 1998-01-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020697-002 TASMAR 200MG TABLET / ORAL 1998-01-29 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N020697-001 TASMAR 100MG TABLET / ORAL AB RLD, RS 1998-01-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020697-002 TASMAR 200MG TABLET / ORAL 1998-01-29 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020697-001 TASMAR 100MG TABLET / ORAL AB RLD, RS 1998-01-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020697-002 TASMAR 200MG TABLET / ORAL 1998-01-29 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020697-001 TASMAR 100MG TABLET / ORAL AB RLD, RS 1998-01-29 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020697-002 TASMAR 200MG TABLET / ORAL 1998-01-29 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020697-001 TASMAR 100MG TABLET / ORAL AB RLD, RS 1998-01-29 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020697-002 TASMAR 200MG TABLET / ORAL 1998-01-29 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020697-001 TASMAR 100MG TABLET / ORAL AB RLD, RS 1998-01-29 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020697-002 TASMAR 200MG TABLET / ORAL 1998-01-29 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020697-001 TASMAR 100MG TABLET / ORAL AB RLD, RS 1998-01-29 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020697-002 TASMAR 200MG TABLET / ORAL 1998-01-29 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020697-001 TASMAR 100MG TABLET / ORAL AB RLD, RS 1998-01-29 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020697-002 TASMAR 200MG TABLET / ORAL 1998-01-29 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N020697-001 TASMAR 100MG TABLET / ORAL AB RLD, RS 1998-01-29 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N020697-002 TASMAR 200MG TABLET / ORAL 1998-01-29 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N020697-001 TASMAR 100MG TABLET / ORAL AB RLD, RS 1998-01-29 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N020697-002 TASMAR 200MG TABLET / ORAL 1998-01-29 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N020697-001 TASMAR 100MG TABLET / ORAL AB RLD, RS 1998-01-29 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N020697-002 TASMAR 200MG TABLET / ORAL 1998-01-29 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N020697-001 TASMAR 100MG TABLET / ORAL AB RLD, RS 1998-01-29 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N020697-002 TASMAR 200MG TABLET / ORAL 1998-01-29 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N020697-001 TASMAR 100MG TABLET / ORAL AB RLD, RS 1998-01-29 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N020697-002 TASMAR 200MG TABLET / ORAL 1998-01-29 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N020697-001 TASMAR 100MG TABLET / ORAL AB RLD, RS 1998-01-29 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N020697-002 TASMAR 200MG TABLET / ORAL 1998-01-29 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N020697-001 TASMAR 100MG TABLET / ORAL AB RLD, RS 1998-01-29 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N020697-002 TASMAR 200MG TABLET / ORAL 1998-01-29 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N020697-001 TASMAR 100MG TABLET / ORAL AB RLD, RS 1998-01-29 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N020697-002 TASMAR 200MG TABLET / ORAL 1998-01-29 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N020697-001 TASMAR 100MG TABLET / ORAL AB RLD, RS 1998-01-29 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N020697-002 TASMAR 200MG TABLET / ORAL 1998-01-29 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N020697-001 TASMAR 100MG TABLET / ORAL AB RLD, RS 1998-01-29 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N020697-002 TASMAR 200MG TABLET / ORAL 1998-01-29 bb7c543d1eb4…
Observed Orange Book normalized TE history# Additional Listing Data#
Finished product Yes
Brand name base Tasmar
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength TOLCAPONE 100 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination CIF6334OLY Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 153655 Internal RxNorm lookup 200220 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0187-0938-01 Tasmar 90 in 1 BOTTLE TABLET, FILM COATED 90 13 0187-0938-07 Tasmar 21 in 1 BOTTLE TABLET, FILM COATED 21 13
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded Tolcapone ACTIVE INGREDIENT CIF6334OLY TASMAR (TOLCAPONE) TABLET, FILM COATED [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] 8 Tolcapone ACTIVE MOIETY CIF6334OLY TASMAR (TOLCAPONE) TABLET, FILM COATED [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] 8 CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS INACTIVE INGREDIENT L11K75P92J TASMAR (TOLCAPONE) TABLET, FILM COATED [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] 8 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U TASMAR (TOLCAPONE) TABLET, FILM COATED [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] 8 ethylcelluloses INACTIVE INGREDIENT 7Z8S9VYZ4B TASMAR (TOLCAPONE) TABLET, FILM COATED [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] 8 ferric oxide red INACTIVE INGREDIENT 1K09F3G675 TASMAR (TOLCAPONE) TABLET, FILM COATED [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] 8 ferric oxide yellow INACTIVE INGREDIENT EX438O2MRT TASMAR (TOLCAPONE) TABLET, FILM COATED [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] 8 Lactose Monohydrate INACTIVE INGREDIENT EWQ57Q8I5X TASMAR (TOLCAPONE) TABLET, FILM COATED [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] 8 magnesium stearate INACTIVE INGREDIENT 70097M6I30 TASMAR (TOLCAPONE) TABLET, FILM COATED [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] 8 povidone K30 INACTIVE INGREDIENT U725QWY32X TASMAR (TOLCAPONE) TABLET, FILM COATED [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] 8 sodium lauryl sulfate INACTIVE INGREDIENT 368GB5141J TASMAR (TOLCAPONE) TABLET, FILM COATED [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] 8 sodium starch glycolate type a potato INACTIVE INGREDIENT 5856J3G2A2 TASMAR (TOLCAPONE) TABLET, FILM COATED [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] 8 talc INACTIVE INGREDIENT 7SEV7J4R1U TASMAR (TOLCAPONE) TABLET, FILM COATED [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] 8 titanium dioxide INACTIVE INGREDIENT 15FIX9V2JP TASMAR (TOLCAPONE) TABLET, FILM COATED [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] 8 triacetin INACTIVE INGREDIENT XHX3C3X673 TASMAR (TOLCAPONE) TABLET, FILM COATED [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] 8
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0187-0938 TASMAR (TOLCAPONE) TABLET, FILM COATED [BAUSCH HEALTH US LLC] 13 Current NDC, Legacy NDC, 2 package rows 20210105_a0e47a9d-78e7-4523-983a-aa259f221736.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 0187-0938-01 00187093801 90 TABLET, FILM COATED in 1 BOTTLE (0187-0938-01) 2004-07-27 0000-00-00 No No Current 0187-0938-07 00187093807 21 in 1 BOTTLE Historical